Antonio C. B.
- Country
- Italy
- Department
- Medical Oncology
Research Overview
- Dose-Escalation Study of Zongertinib in Patients with Advanced Non-Small Cell Lung Cancer and Solid Tumors with HER2 Aberrations
- Evaluation of Debio 0123 Combined with Carboplatin and Etoposide in Adults with Recurrent or Progressive Small Cell Lung Cancer Post-Platinum Therapy
- Phase 3 Randomized Study of Nivolumab and Ipilimumab with Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 442 of 678 partner sites.
Specializations
Thoracic Oncology
Antonio Calles Blanco is active in clinical research for non-small cell lung cancer, small cell lung cancer, and other advanced thoracic malignancies, with a strong focus on treatment-resistant and biomarker-selected disease.
- Non-small cell lung cancer
- Small cell lung cancer
- Squamous cell carcinoma of the head and neck
- Malignant pleural mesothelioma
His work also extends to molecularly defined lung cancer populations, including tumors with actionable genomic alterations and advanced disease requiring systemic innovation.
Breast and Gynecologic Oncology
He is involved in studies of hormone receptor-positive breast cancer, HER2-negative breast cancer, triple-negative breast cancer, and advanced gynecologic cancers such as ovarian cancer and endometrial cancer.
- Hormone receptor-positive breast cancer
- HER2-negative breast cancer
- Triple-negative breast cancer
- Ovarian and endometrial cancer
His portfolio includes interest in HER2-positive disease, recurrent malignancy, and endocrine-resistant breast cancer.
Gastrointestinal and Hepatobiliary Oncology
His clinical trial activity includes hepatocellular carcinoma, biliary tract cancer, gastric cancer, gastroesophageal junction adenocarcinoma, and pancreatic ductal adenocarcinoma.
- Hepatocellular carcinoma
- Biliary tract cancer
- Gastric and gastroesophageal junction cancer
- Pancreatic cancer
He is also engaged in research on colorectal cancer and advanced solid tumors with liver and digestive system involvement.
Hematologic Malignancies
Antonio Calles Blanco participates in trials for diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia.
- Diffuse large B-cell lymphoma
- Chronic lymphocytic leukemia
- Multiple myeloma
- Acute myeloid leukemia
His research also covers high-risk myelodysplastic syndromes, relapsed or refractory lymphoid disease, and advanced cellular therapy settings.
Immune-Mediated and Inflammatory Disease
He is involved in clinical studies of systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, and hidradenitis suppurativa.
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Atopic dermatitis
- Inflammatory bowel disease
His therapeutic interests also include ulcerative colitis, Crohn’s disease, systemic sclerosis, and other immune-mediated conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.